Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV

Abstract : Predicting vaccine efficacy remains a challenge. We used a systems vaccinology approach to identify early innate immune correlates of antibody induction in humans receiving the Ebola vaccine rVSV-ZEBOV. Blood samples from days 0, 1, 3, 7, and 14 were analyzed for changes in cytokine levels, innate immune cell subsets, and gene expression. Integrative statistical analyses with cross-validation identified a signature of 5 early innate markers correlating with antibody titers on day 28 and beyond. Among those, IP-10 on day 3 and MFI of CXCR6 on NK cells on day 1 were independent correlates. Consistently, we found an early gene expression signature linked to IP-10. This comprehensive characterization of early innate immune responses to the rVSV-ZEBOV vaccine in humans revealed immune signatures linked to IP-10. These results suggest correlates of vaccine-induced antibody induction and provide a rationale to explore strategies for augmenting the effectiveness of vaccines through manipulation of IP-10.
Liste complète des métadonnées

https://hal.inria.fr/hal-01579246
Contributeur : Boris Hejblum <>
Soumis le : samedi 6 octobre 2018 - 10:40:58
Dernière modification le : lundi 8 octobre 2018 - 08:29:20

Fichier

mmc4.pdf
Publication financée par une institution

Identifiants

Citation

Anne Rechtien, Laura Richert, Hadrien Lorenzo, Gloria Martrus, Boris P. Hejblum, et al.. Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV. Cell Reports , Elsevier Inc, 2017, 20 (9), pp.2251 - 2261. 〈10.1016/j.celrep.2017.08.023〉. 〈hal-01579246〉

Partager

Métriques

Consultations de la notice

179

Téléchargements de fichiers

5